Showing results (81-90 of 243) with videos related to
Sort By:
Pageof 25
Journal of Hypertension|March 23, 2002
Functional cross-talk between angiotensin II and epidermal growth factor receptors in NIH3T3 fibroblastsPaola De Paolis, Antonio Porcellini, Carmine Savoia, et al.Thrombosis and Haemostasis|May 1, 2009
Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levelsBruna Gigante, Max Vikström, Linda Strömqvist Meuzelaar, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 26, 2015
Clopidogrel Resistance after Minor Ischemic Stroke or Transient Ischemic Attack is Associated with Radiological Cerebral Small-Vessel DiseaseAnnika Lundström, Håkan Wallén, Magnus von Arbin, et al.European Journal of Preventive Cardiology|October 14, 2021
Physical activity attenuates cardiovascular risk and mortality in men and women with and without the metabolic syndrome - a 20-year follow-up of a population-based cohort of 60-year-oldsElin Ekblom-Bak, Mats Halldin, Max Vikström, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 9, 2024
Translating trial results into interpretable risk estimates: Systematic analysis of cardiorenal outcome trials of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitorsAlessandro Rizzi, David E Kloecker, Dario Pitocco, et al.The Thoracic and Cardiovascular Surgeon|December 16, 2014
Paravertebral Analgesia in Video-Assisted Thoracic Surgery: A New Hybrid Technique of Catheter Placement for Continuous Anesthetic InfusionUgo Cioffi, Federico Raveglia, Alessandro Rizzi, et al.Diabetes & Metabolic Syndrome|January 23, 2024
Effect of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on time to outcome in type 2 diabetes cardiorenal outcome trialsAlessandro Rizzi, David E Kloecker, Dario Pitocco, et al.Plos One|April 22, 2017
IgM antibodies to oxidized phosphatidylserine as protection markers in cardiovascular disease among 60-year oldsJohan Frostegård, Jun Su, Sudhir Sing, et al.Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|November 28, 2017
Comorbidities in relation to fatality of first myocardial infarctionHedley Knewjen Quintana, Imre Janszky, Alkass Kanar, et al.Translational Stroke Research|January 27, 2020
Prognostic Value of Circulating Microvesicle Subpopulations in Ischemic Stroke and TIAAnnika Lundström, Fariborz Mobarrez, Elisabeth Rooth, et al.Pageof 25